Answers are grounded in this paper and cite their sources.
Sepsis is a heterogeneous clinical syndrome estimated to account for approximately 20% of global deaths annually 1 .Despite decades of mechanistic research, no "sepsis-specific" therapeutics have been shown to mitigate the morbidity and mortality of this common disease state.Instead, declining sepsis case-fatality rates are largely attributed to the rapid recognition of sepsis physiology and optimized intervention via the utilization of clinical guidelines and treatment bundles 2 .The role of infectious disease (ID) specialists in guideline-directed sepsis care, however, is uncertain.In this issue of Open Forum Infectious Diseases, Suarez-Robles and colleagues investigate the impact of early (within 12 hours) ID specialist evaluation of septic patients on subsequent antimicrobial de-escalation (Suarez-Robles et al.CITATION).Utilizing an existing "sepsis code" program at an academic hospital in Spain, the authors studied a large cohort of patients who triggered a sepsis alert (1546 patients in the overall cohort, 824 of which were included in the propensity matched groups).The primary result of the matched analysis demonstrated a higher likelihood of antimicrobial de-escalation within 5 days in the group with early ID evaluation.Importantly, this statistically significant association persisted regardless of the presence or absence of informative microbiologic testing / diagnostics.This crucial distinction suggests a clinical impact of ID specialists' management that surpasses simply following up pending microbiologic testing and adjusting antibiotic regimens as appropriate.
No takes yet. Share an insight, caveat, or question.
Colbert et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: